Table 1
 Distribution of
BRCAl
founder mutations in cancer cases and controls (number (%))
C61G
4153delA
5382insC
Total
Breast
15 (0.7%)
1 (0.05%)
43 (2.1%)
59 (2.9%)
Ovarian
13 (3.6%)
8 (2.2%)
28 (7.7%)
49 (13.5%)
Controls
1 (0.05%)
1 (0.05%)
4 (0.2%)
6 (0.3%)